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This study presents the neurologic phenotypes of 2 brothers with a novel homozygous
COL4A1 mutation that was identified in a large Turkish consanguineous cohort of neuro-
genetic diseases.
Methods
Whole-exome sequencing and bioinformatic analysis of consanguineous families with children
affected by early-onset, neurogenetic disorders was performed using the RD-Connect Genome-
Phenome Analysis Platform. We also performed clinical, EEG, and neuroimaging analyses in
unaffected siblings and parents.
Results
We have identified a homozygous missense mutation in COL4A1 (p.Gly1278Ser, NM_
001845.5:c.3832G>T) in 2 siblings affected by small vessel brain disease with periventricular
leukoencephalopathy and ocular defects. Presenting symptoms included mild weakness,
hemiparetic gait, pyramidal findings, and seizures, whereas their intellectual and behavioral
functions were normal. Both parents and 5 of the siblings (3 boys and 2 girls) were hetero-
zygous for the variant. They did not show any clinical or laboratory signs of small vessel disease.
Conclusions
COL4A1 has previously been associated with dominant small vessel disease of the brain and
other organs, manifesting with high penetrance in heterozygous mutation carriers. Our findings
provide evidence that COL4A1-related encephalopathy can be inherited in an autosomal re-
cessive manner, which is important for counseling, prognosis, and treatment. Genotype-
phenotype correlations remain to be established.
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Type IV collagens are expressed in basement membranes
only. Six different genes in humans encode 6 different
alpha-chains (α1-α6), which form trimers with each other
in 3 combinations: α1α1α2, α3α4α5, and α5α5α6. The
classical type IV collagens, COL4A1 and COL4A2, are the
major forms expressed during early development.1 The
human COL4A1 gene, located on chromosome 13
(13q34), is 158,199 bp long with 52 exons, and it encodes
alpha-1 (α1) chain. COL4A1 protein contains a 27 amino
acid signal peptide, a 7S domain at the N-terminal, a col-
lagenous domain that forms a triple helix with other col-
lagens, and a noncollagenous region (NC1) at the carboxy
terminal.
COL4A1-related disorders are inherited in an autosomal
dominant manner or occur de novo. The proportion of
cases caused by a de novo pathogenic variant is estimated to
be at least 27%–54%.2,3 Phenotypes include porencephaly
type 1 (Online Mendelian Inheritance in Man [OMIM]#
175780), brain small vessel disease with or without ocular
anomalies (OMIM# 607595), tortuosity of retinal arteries
(OMIM# 180000), and hereditary angiopathy with ne-
phropathy, aneurysms, and muscle cramps (HANAC)
(OMIM# 611773).4,5 Intrafamilial and interfamilial vari-
ability are common findings in all COL4A1-related
disorders.
Herein, we describe a homozygous missense COL4A1 variant
in 2 brothers, from a first-degree consanguineous Turkish
family, both of whom have small vessel brain disease including
small internal porencephaly, associated with eye defects such
as retinal vessel tortuosity, Axenfeld-Rieger anomaly, cataract,
and glaucoma. Similar to the other COL4A1 cases in the
literature, this particular COL4A1 variant (NM_001845.5:
c.3832G>T, NP_001836.3:p.Gly1278Ser) affects a glycine
residue, interrupting the Gly-Xaa-Yaa amino acid repeat.
However, in contrast to most of the previously reported
glycine variants in COL4A1-related disorders, this variant
causes defects that are inherited in an autosomal recessive
manner.
Methods
Description of the study
Analysis of the family was performed as part of a large in-
ternational genomic study on 200 consanguineous Turkish
families that aims to determine the genetic burden of con-
sanguineous marriages on neurogenetic diseases in Turkey by
3 centers in Turkey and 2 centers in the United Kingdom.
Whole-exome sequencing (WES) was performed at the
BROAD Institute ofMIT-Harvard, and bioinformatic analysis
was performed at the Centro Nacional de Ana´lisis Geno´mico
(CNAG)-CRG (Barcelona, Spain).
Standard protocol approvals, registrations,
and patient consents
The study was approved by the Dokuz Eylul University
Clinical Research Ethics Committee (approval no. 302-
SBKAEK 2016/03-01). Written consents of the patients and
their parents were obtained. Written consent to publish
photographs of the patients was also obtained.
Clinical evaluation
Phenotypic studies included clinical evaluation, funduscopic
examination, brain MRI, cerebral magnetic resonance angi-
ography, abdominal ultrasonography, echocardiography,
electrocardiography, urinalysis, and serum biochemical and
hemogram levels of our affected patients and unaffected
members of family. Written informed consent was obtained
by one of the coauthors (A.Y.). Phenotypic data were col-
lected with standard forms organized to include Human
Phenotype Ontology terms, and data were entered into the
PhenoTips database.
WES and validation
WES was performed on DNA obtained from probands 2 and
3, and both parents, at the Broad Institute of MIT/Harvard.
Libraries from DNA samples (>250 ng of DNA, at >2 ng/μL)
were created with an Illumina exome capture kit (38 Mb
target) and sequenced (150 bp paired-end reads) to cover
>90% of targets at 20× and a mean target coverage of >80×.
Sample identity quality assurance checks were performed on
each sample. The exome sequencing data was demultiplexed,
and each sample’s sequence data were aggregated into a single
Picard BAM file.
Detection of COL4A1 variant and
segregation analysis
Sequencing data were processed at the CNAG, Barcelona, and
data analysis was performed on the RD-Connect Genome-
Phenome Analysis Platform6 using standard filtering criteria
for rare diseases, including minor allele frequency <0.01,
variant effect predictor = mod/high, and Combined
Annotation-Dependent Depletion (CADD) >20. The
COL4A1 variant (NM_001845.5:c.3832G>A, NP_001836.3:
p.Gly1278Ser) was tested by Sanger sequencing in both af-
fected siblings, both parents and 6 unaffected siblings.
Glossary
CADD = Combined Annotation-Dependent Depletion; CNAG = Centro Nacional de Ana´lisis Geno´mico; gnomAD =
Genome Aggregation Database;HANAC = hereditary angiopathy with nephropathy, aneurysms, and muscle cramps;OMIM =
Online Mendelian Inheritance in Man; PVL = periventricular leukoencephalopathy; THR = triple-helix region;WES = whole-
exome sequencing.
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Data availability
WESdatawere analyzed on theRD-ConnectGenome-Phenome
Analysis Platform, and anonymized data will be shared with any




A 16-year-old boy was admitted at age 8 years. He had mild
hemiparesis on the right side that started at age 8 years (figure
1A). His parents noticed this complaint when he was walking
independently at age 18 months. He had a history of partial
epilepsy with reduced consciousness that started at age 1 year
and incompletely controlled by oral Na+ valproate treatment.
He had seizures usually twice a month, typically complex
partial seizures or complex partial seizures evolving to gen-
eralized seizures localized to the right side. The patient was
previously followed up with a diagnosis of perinatal hypoxic-
ischemic sequelae at another center. His seizures were usually
prolonged (>5 minutes) and sometimes lasted for about half
an hour, which was compatible with status epilepticus.
He was born at home by spontaneous vaginal delivery with
the help of a midwife without complication. Birth weight,
head circumference, and height were unknown; therefore, the
Apgar score could not be calculated. The mother had neither
related significant medical history nor regular antenatal
medical follow-up. Fetal movements during the antenatal
period were normal.
His early motor development was normal, except having mild
hemiparesis that was noticed at age 18 months. The patient’s
hand preference during the first 2 years is not known. The
patient started walking without support at age 18 months. His
social and language milestones were normal. At age 6 months,
bilateral cataract was noticed. He was operated for cataract and
glaucoma, and prophylactic glaucoma treatment was started.
His initial physical examination revealed a marfanoid appear-
ance with disproportionately long arms and legs comparedwith
the trunk. However, he had no signs of wrist (Walker) or
thumb (Steinberg), or joint hypermobility or arachnodactyly,
that are typical signs of Marfan syndrome. Cranial nerve
examinations and eyemovements in all directions were normal.
He was using hypermetropic glasses. Ophthalmologic exami-
nation revealed bilateral megalocornea, trabeculodysgenesis,
nebular corneal opacity, hypoplastic optic discs, and tortuosity
of retinal venous vessels, findings that were suggestive of
a congenital cataract and glaucoma (figure 1G). Neurologic
examination revealed mild unilateral weakness with hemi-
paretic gait, increased reflexes, and Babinski sign on the right.
He was making good academic progress at school and com-
munication with the social environment.
Figure 1 Selection of phenotypes, brain magnetic reso-
nance images, and ocular defects of 2 cases
(A) Case 1 (homozygous missense [p.Gly1278Ser] in COL4A1), aged 16 years
at the last follow-up, had good academic skills with amarfanoid appearance,
mild hemiparesis, partial seizures, and ocular defects. EEG was abnormal.
BrainMRI findings showed that diffuse PVLwith left ventricular enlargement
with small porencephaly and thinning of the body part of the corpus cal-
losum were stable even after 6 years. (B) Case 2 (homozygous missense
[p.Gly1278Ser] in COL4A1), aged 10 years at the last follow-up, had good
academic skills with mild hemiparesis and ocular defects. EEG was normal.
Brain MRI findings showed that PVL with right mild ventricular enlargement
was stable even 6 years later. (C) T1-weighted sagittal image of case 1,
showing thinning of the body part of the corpus callosum. (D) T2-weighted
axial image of case 2, showing diffuse PVL with right mild ventricular en-
largement. (E) T2-weighted axial image of cases 1, showing diffuse PVL with
left ventricular enlargement and small porencephalic cyst. (F) T2-weighted
axial image of cases 2, showing diffuse bilateral deep white matter leu-
koencephalopathy. (G) Ophthalmoscopic examination of case 1 showing
hypoplastic optic discs and tortuosity of retinal veins. PVL = periventricular
leukoencephalopathy.
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His whole blood and routine biochemistry analyses with serum
creatine kinase levels (80 units/L) were normal. EEG exami-
nation revealed frequent and irregular pathologic high-voltage
theta- and alpha-wave groups with multifocal sharp and spike
discharges in the left hemisphere. Brain background activity
was normal.
Brain MRI of patient 1 showed diffuse periventricular leu-
koencephalopathy (PVL) with left ventricular enlargement,
small porencephalic cysts, and thinning of the body part of the
corpus callosum (figure 1, C and E). Brain MRI analysis was
performed twice, at ages 3 and 9 years, and no differences
were seen between the 2 MRI analyses. Brain MRI angiog-
raphy analysis was normal at age 9 years.
His epileptic seizures were consistent with complex partial
seizures evolving to generalized seizures according to the
International League Against Epilepsy 1989 classification.
Appropriate oral oxcarbazepine was introduced instead of
sodium valproate. After the treatment, no seizures were ob-
served during the 6-year follow-up of the patient.
In the following years, further diagnostic tests (serum levels of
homocysteine, B12 vitamin, folic acid, lactate, pyruvate, bio-
tinidase, and analyses of serum quantitative amino acids,
acylcarnitines by tandem mass spectrometry, urine organic
acid, serum arylsulfatase enzyme, and mitochondrial DNA
sequence) were normal. Cardiac examination, echocardio-
gram, ECG, urine microscopic examination, and renal ultra-
sound were normal. His blood pressure and respiratory
function were normal. The patient had a stable clinical course,
and there were no complaints such as stroke, muscle cramps,
and migraine-type headache.
Case 2
A 10-year-old brother was admitted with left-sided hemiparesis
at age 2 years. This complaint was first noticed at age 16
months, when he began walking without assistance. He had no
history of epileptic seizures. This case has also been followed up
with a diagnosis of cerebral palsy due to perinatal hypoxic-
ischemic encephalopathy in another center. The patient was
born at term, with a natural delivery with the help of a midwife
at homewithout complication. His Apgar score was not known.
Birth weight, head circumference, and height were unknown.
Cranial nerve examinations and eye movements in all direc-
tions were normal. There was no ptosis, and he used glasses
for hypermetropia. The patient’s eye examination indicated
mild depth in the anterior camera, as well as mild fibrils and
spots in front of the lens of both eyes, which was compatible
with the preliminary finding of glaucoma. The patient’s first
neurologic and physical examination revealed mild weakness
with hemiparetic gait that was more prominent in the leg,
increased reflexes, Babinski sign on the left.
Brain MRI showed diffuse PVL with right mild ventricular en-
largement (figure 1, D andF). BrainMRI analysis was performed
when the patient was aged 3 and 8 years. There were no dif-
ferences in MRI findings that were performed with 5-year in-
terval. BrainMRI angiography analysis was normal at age 8 years.
He was making good academic progress at school and com-
munication with the social environment, like his affected brother.
Parents are first cousins; they have 8 children in total; 3
daughters (13 years old, 20 years old, and 23 years old) and 3
sons (18 years old, 19 years old, and 22 years old) are un-
affected. They did not have any complaints such as cerebral
stroke, migraine headache, muscle cramps, heart, kidney, or
any eye disease. There were no similar complaints in the first-
degree relatives of parents either.
Cardiac examination, echocardiography, ECG, and renal ul-
trasound evaluations were normal. Funduscopic, cardiac, re-
nal, and cerebral MRI evaluations and serum creatine kinase
levels were normal in all unaffected family members including
their parents. Of note, none of the siblings or the parents were
clinically affected or showed any sign of glaucoma.
Genetic analyses
WES of the 2 affected brothers and their parents identified
a novel homozygous missense variant (NM_001845.5:
c.3832G>A; NP_001836.3:p.Gly1278Ser) in exon 43 of
COL4A1 (chr13:110169673, GRCh38.p12). Both affected
siblings were homozygous, while both parents were heterozy-
gous for the variant (figure 2). The variant is predicted to be
pathogenic by MutationTaster, PolyPhen2, and Sorting In-
tolerant From Tolerant and has a CADD score of 28.2. Al-
though the variant is defined in the Single Nucleotide
Polymorphism database with identifier rs757453900, it is
missing from the ClinVar database. The allele frequency is
0.000001592 according to the Genome Aggregation Database
(gnomAD), with no homozygotes, but 4 heterozygotes out of
251,314 allele counts of healthy controls.7 The variant was
missing from a cohort of 1,182 ethnically matched Turkish
control individuals (TUBITAK MAM-GMBE data set).8
Gly1278 is a highly conserved residue (GERP = 5.47) and
Gly1278Ser mutation interrupts the Gly-Xaa-Yaa amino acid
repeats, similar to the previously reported pathogenic COL4A1
variants that affect glycine residues in Gly-Xaa-Yaa repeats.9
Multiple sequence alignment of the protein sequence flanking
Gly1278 to those regions flanking the other reported Gly-to-
Ser variants in the COL4A1 triple-helix region (THR) does not
point to any obvious differences that might explain the re-
cessive inheritance of the associated pathologies (figure 3).
However, it is intriguing that sequences flanking glycines with
Gly-to-Ser variants in gnomAD show higher sequence simi-
larity to each other compared with the others.
Discussion
The spectrum of COL4A1-related disorders includes small
vessel brain disease of varying severity including por-
encephaly, variably associated with eye defects (retinal arterial
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tortuosity, Axenfeld-Rieger anomaly, and cataract) and sys-
temic findings (kidney involvement, muscle cramps, cerebral
aneurysms, Raynaud phenomenon, cardiac arrhythmia, and
hemolytic anemia).5
The inheritance of COL4A1- and COL4A2-related disorders
is dominant: In a recent study, the authors reported 44 new
patients, 24 due to de novomutations; they also calculated the
number of previously reported COL4A1 and COL4A2
mutations to be 63 and 6, respectively.3 Eight of 44 COL4A1/
COL4A2 mutations associated with epilepsy were de novo.
However, 24 of them were of unknown inheritance. There-
fore, the proportion of cases caused by a de novo pathogenic
variant can be estimated to be at least 18%–54%, whereas
another study suggested it to be at least 27%.2 Of interest,
incomplete penetrance of COL4A1 mutations was reported,3
and the authors suggested that it may contribute to increased
disease severity over generations. Similarly, to explain the
phenomenon of the same COL4A1 variant causing disease in
offspring but not in the parents, it was postulated that
COL4A1 mutations should be regarded as risk factors that
interact with modifiers to cause disease. However, the family
reported here with both affected individuals being homozy-
gous and 5/6 unaffected siblings being heterozygous cannot
simply be explained by incomplete penetrance or generational
gradient in phenotype.
In this study, we have identified a missense variant in COL4A1
(p.Gly1278Ser) that segregated in a clearly recessive trait with
perinatal cerebral hemorrhage and diffuse PVL with ocular
defects among 2 brothers, 6 unaffected siblings, and their parents.
Initially, cranial MRIs of the cases were reported to be con-
sistent with leukodystrophy or perinatal hypoxic-ischemic en-
cephalopathy by 3 different neuroradiologists at the same time.
However, the clinical and radiologic findings of the patients
were similar. Moreover, their parents were first-degree relatives,
and there was no history of perinatal complications in 2 cases.
Therefore, possibility of neurogenetic disease was considered.
The most abundant type IV collagens COL4A1 and COL4A2
both have collagenous triple-helical domains characterized by
repetition of Gly-X-Y motifs, where X and Y are variable
amino acids. Starting at the noncollagenous (NC1) domains,
2 molecules of COL4A1 and 1molecule of COL4A2 assemble
together to form a trimer, namely α1α1α2 (IV) collagen.
Stability of this trimer is dependent on intermolecular inter-
actions at the THR and glycine residues are critical to pre-
serving the trimer structure. By impairing heterotrimer
biosynthesis, substitutions of the glycine residues are the most
frequent pathogenic mutations in COL4A1- and COL4A2-re-
lated disorders, and all of themissensemutations in the THRof
both proteins affect glycine residues.10,11 Moreover, 66% (39/
59) of the reported glycinemutations inTHR are conversion of
glycine to charged amino acids (glutamic acid, arginine, and
aspartic acid), and only 16% (8/59) of pathogenic missense
mutations are Gly-to-Ser substitutions.3 Importantly, glycine
mutations on 1 allele are usually expressed andmake 50% of the
monomers. Through the assembly process, those mutated
monomers disturb around 90% of the heterotrimers, explaining
their dominant negative effect. In addition, among the “benign”
and “likely benign” variants of COL4A1 reported in ClinVar,
there is only 1 missensemutation (rs150182714, p.Gly332Arg)
that affects glycines in the THR, underscoring the mutational
intolerance of glycine residues in this critical region12 and
making Gly1278Ser substitution an extremely rare example. Of
note, well-known examples of recessively inherited collagen
mutations are observed in COL6A2 that cause Bethlem my-
opathy, Ullrich congenital muscular dystrophy, and congenital
myosclerosis; however, none of the recessive mutations in
COL6A2 are glycine substitutions.13 It is possible that the
Figure 2 COL4A1 NM_001845.5:c.3832G>A p.Gly1278Ser variant segregates with disease
Both parents and 5 of the 6 unaffected siblings are heterozygous for the variant, while both affected cases are homozygous. One unaffected sibling does not
carry this variant. Number of “red dots” indicates the number of COL4A1 c.3832G>A alleles for each family member.
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sequence flanking Gly1278 has a structural or functional
property that causes tolerance for glycine missense mutations.
Such context-specific effects were reported for COL6A3.13
However, comparison of the sequence context of other path-
ogenic Gly-to-Ser mutations in COL4A1 to that of Gly1278
does not provide an obvious explanation to the unique re-
cessive inheritance pattern (figure 3). Yet, higher sequence
similarity of “tolerant” Gly-to-Ser substitutions to each other
compared with other Gly-to-Ser substitutions implies a struc-
tural and/or functional basis that remains to be explored. It is
possible that Gly1278Ser variant interferes with the post-
translational processing of the monomer and reduces its in-
teraction with wild-type monomers, thereby allowing
formation of wild-type trimers in the heterozygous state. Fur-
ther molecular studies are required to test this hypothesis.
Others did not observe a correlation between the severity of
the disease and the location of the mutations.3 On the other
hand, phenotypic heterogeneity for COL4A1 mutations was
reported even on a pure mouse genetic background, likely
due to variation in the severity of stress factors.14
Considering the consistency in our pedigree, it is possible
that the recessive inheritance pattern could be due to a fa-
vorable combination of protective modifiers that alleviates or
reduces the effects of stress factors on basement membranes.
This hypothesis is in line with the previously proposed “risk
factor model.”2
Before 2005, congenital porencephaly on CT or MRI had
usually been considered as the result of an external insult such
as traumatic or hypoxic-ischemic birth injury. With the gen-
eration of mouse models of COL4A1-related disorder,14,15
COL4A1 mutations were reported as the primary cause of
hereditary porencephaly with an autosomal dominant
inheritance.2
Over the years, variants in COL4A1 have been identified in
a wide range of diseases, including porencephaly,16 familial
and sporadic small vessel disease and hemorrhagic
stroke,15,17,18 leukoencephalopathy,19 HANAC syndrome,10
Walker-Warburg syndrome,21 and isolated ophthalmologic
anomalies.19–21 COL4A1-related disorders represent a single
disease with great variability in expressivity and age at onset.
The complaints of our 2 brother cases were noticed by the
parents in the their first 18 months of life when they started to
walk independently. Of note, affected brothers are 2 of the 3
youngest of the 8 siblings. Although we cannot rule out the
possibility of parents and/or unaffected siblings being pre-
symptomatic, absence of similar complaints within the
grandparents or cousins argues against this possibility.
In the literature, previously reported patients demonstrate
severe clinical manifestations including porencephalic cysts
on brain MRI as the most frequently reported finding,
seizures, developmental delay, intellectual disability and
behavioral abnormalities, microcephaly, and motor abnor-
malities on neurologic examination, with involvement of
both abnormal pyramidal and extrapyramidal signs.3 In this
study, cases 1 and 2 showed diffuse PVL with left ventric-
ular enlargement with small porencephalic cysts, thinning
of the body part of the corpus callosum, and diffuse PVL
with right mild ventricular enlargement in MRI analyses,
respectively. Although our cases had the pyramidal find-
ings, their intellectual and behavioral functions were quite
good. Their neuromotor developmental skills were normal,
and neither one had microcephaly. Case 1 had epilepsy
since age 1 year.
In this study, we describe a rare case of autosomal recessively
inherited homozygous missense COL4A1 variants in 2
brothers, parents of whom are first-degree cousins, with small
vessel brain disease including small internal porencephaly,
associated with eye defects such as retinal vessels tortuosity,
Axenfeld-Rieger anomaly, cataract, and glaucoma. Enlarged
clinical spectrum and an unusual inheritance pattern for
COL4A1 variants will improve the effectiveness of targeted
screening of the COL4A1 gene and appropriate clinical
management of the patients.
Figure 3 Multiple sequence alignment of sequences
flanking glycines in the triple-helix region (THR)
of COL4A1 that are known to be affected by Gly-
to-Ser substitutions
T-Coffee Expresso and T-Coffee alignments show higher similarity between
those that flank a glycine with at least 1 nonpathogenic Gly-to-Ser sub-
stitution according to gnomAD (indicated by “star” sign). Number of heter-
ozygotes in gnomAD, ACMG classification, and ClinVar status of variants are
indicated next to T-Coffee Expresso similarity scores. ACMG = American
College of Medical Genetics; gnomAD = Genome Aggregation Database;
MSA = Multiples Sequence Alignment.
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